{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:09Z","timestamp":1740120069343,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12185-024-03845-6","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:14:50Z","timestamp":1726661690000},"page":"750-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement"],"prefix":"10.1007","volume":"120","author":[{"given":"Ismail","family":"Elbaz Younes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia T.","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-7550","authenticated-orcid":false,"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"5","key":"3845_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","volume":"16","author":"C Schmid","year":"1992","unstructured":"Schmid C, Kirkham N, Diss T, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol. 1992;16(5):455\u201366.","journal-title":"Am J Surg Pathol"},{"issue":"1\u20132","key":"3845_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.beha.2016.09.005","volume":"30","author":"MA Piris","year":"2017","unstructured":"Piris MA, Onaindia A, Mollejo M. Splenic marginal zone lymphoma. Best Pract Res Clin Haematol. 2017;30(1\u20132):56\u201364.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"3845_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","volume":"4","author":"C Thieblemont","year":"2003","unstructured":"Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol. 2003;4(2):95\u2013103.","journal-title":"Lancet Oncol"},{"issue":"11","key":"3845_CR4","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","volume":"26","author":"A Conconi","year":"2015","unstructured":"Conconi A, Franceschetti S, von Hohenstaufen KA, Margiotta-Casaluci G, Stathis A, Moccia AA, et al. Histologic transformation in marginal zone lymphomasdagger. Ann Oncol. 2015;26(11):2329\u201335.","journal-title":"Ann Oncol"},{"issue":"4","key":"3845_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3324\/haematol.2009.011049","volume":"95","author":"L Baseggio","year":"2010","unstructured":"Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, et al. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica. 2010;95(4):604\u201312.","journal-title":"Haematologica"},{"issue":"48","key":"3845_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jncimonographs\/lgu011","volume":"2014","author":"PM Bracci","year":"2014","unstructured":"Bracci PM, Benavente Y, Turner JJ, Paltiel O, Slager SL, Vajdic CM, et al. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):52\u201365.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"3845_CR7","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1038\/ncomms6751","volume":"6","author":"J Vijai","year":"2015","unstructured":"Vijai J, Wang Z, Berndt SI, Skibola CF, Slager SL, de Sanjose S, et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nat Commun. 2015;6:5751.","journal-title":"Nat Commun"},{"issue":"21","key":"3845_CR8","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1002\/cncr.33117","volume":"126","author":"JA Florindez","year":"2020","unstructured":"Florindez JA, Alderuccio JP, Reis IM, Lossos IS. Splenic marginal zone lymphoma: a US population-based survival analysis (1999\u20132016). Cancer. 2020;126(21):4706\u201316.","journal-title":"Cancer"},{"issue":"7","key":"3845_CR9","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"34","key":"3845_CR10","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1200\/JCO.18.00138","volume":"36","author":"JP Alderuccio","year":"2018","unstructured":"Alderuccio JP, Zhao W, Desai A, Gallastegui N, Ramdial J, Kimble E, et al. Risk factors for transformation to higher-grade lymphoma and its impact on survival in a large cohort of patients with marginal zone lymphoma from a single institution. J Clin Oncol. 2018;36(34):3370\u201380.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3845_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00428-023-03633-3","volume":"483","author":"A Zamo","year":"2023","unstructured":"Zamo A, van den Brand M, Climent F, de Leval L, Dirnhofer S, Leoncini L, et al. The many faces of nodal and splenic marginal zone lymphomas: a report of the 2022 EA4HP\/SH lymphoma workshop. Virchows Arch. 2023;483(3):317\u201331.","journal-title":"Virchows Arch"},{"issue":"11","key":"3845_CR12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.humpath.2012.01.003","volume":"43","author":"D Hoehn","year":"2012","unstructured":"Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hum Pathol. 2012;43(11):1828\u201338.","journal-title":"Hum Pathol"},{"key":"3845_CR13","first-page":"5761953","volume":"2018","author":"K Algashaamy","year":"2018","unstructured":"Algashaamy K, Tan Y, Mackrides N, Alencar A, Peng JH, Rosenblatt J, et al. Splenic B-cell lymphomas with diffuse cyclin D1 protein expression and increased prolymphocytic cells: a previously unrecognized diagnostic pitfall. Case Rep Hematol. 2018;2018:5761953.","journal-title":"Case Rep Hematol"},{"issue":"1","key":"3845_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2141.1979.tb03676.x","volume":"41","author":"A Enno","year":"1979","unstructured":"Enno A, Catovsky D, O\u2019Brien M, Cherchi M, Kumaran TO, Galton DA. \u201cProlymphocytoid\u201d transformation of chronic lymphocytic leukaemia. Br J Haematol. 1979;41(1):9\u201318.","journal-title":"Br J Haematol"},{"issue":"5","key":"3845_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2021012386","volume":"139","author":"F Bonfiglio","year":"2022","unstructured":"Bonfiglio F, Bruscaggin A, Guidetti F, di Bergamo LT, Faderl M, Spina V, et al. Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood. 2022;139(5):732\u201347.","journal-title":"Blood"},{"key":"3845_CR16","doi-asserted-by":"publisher","first-page":"1073672","DOI":"10.3389\/fonc.2022.1073672","volume":"12","author":"N Mesini","year":"2022","unstructured":"Mesini N, Fiorcari S, Atene CG, Maffei R, Potenza L, Luppi M, et al. Role of Notch2 pathway in mature B cell malignancies. Front Oncol. 2022;12:1073672.","journal-title":"Front Oncol"},{"key":"3845_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151790","volume":"54","author":"S El Hussein","year":"2021","unstructured":"El Hussein S, Khoury JD, Medeiros LJ. B-prolymphocytic leukemia: Is it time to retire this entity? Ann Diagn Pathol. 2021;54: 151790.","journal-title":"Ann Diagn Pathol"},{"issue":"11","key":"3845_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229\u201353.","journal-title":"Blood"},{"key":"3845_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.humpath.2018.09.021","volume":"90","author":"K Zhang","year":"2019","unstructured":"Zhang K, Farrell D, Jeyakumar D, O\u2019Brien S, Zhao X, Rezk SA. Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual event. Hum Pathol. 2019;90:106\u201310.","journal-title":"Hum Pathol"},{"issue":"3","key":"3845_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/10520290500305310","volume":"47","author":"SK Lau","year":"2006","unstructured":"Lau SK, Weiss LM, Zhang Y, Huang Q. Prolymphocytoid transformation of follicular lymphoma with coexpression of CD5 and CD10. Leuk Lymphoma. 2006;47(3):541\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3845_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bjh.17141","volume":"193","author":"B Gailllard","year":"2021","unstructured":"Gailllard B, Cornillet-Lefebvre P, Le QH, Maloum K, Pannetier M, Lecoq-Lafon C, et al. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. Br J Haematol. 2021;193(1):72\u201382.","journal-title":"Br J Haematol"},{"issue":"14","key":"3845_CR22","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1182\/bloodadvances.2022009415","volume":"7","author":"M Grau","year":"2023","unstructured":"Grau M, Lopez C, Navarro A, Frigola G, Nadeu F, Clot G, et al. Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood Adv. 2023;7(14):3695\u2013709.","journal-title":"Blood Adv"},{"issue":"1","key":"3845_CR23","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","volume":"9","author":"C Jaramillo Oquendo","year":"2019","unstructured":"Jaramillo Oquendo C, Parker H, Oscier D, Ennis S, Gibson J, Strefford JC. Systematic review of somatic mutations in splenic marginal zone lymphoma. Sci Rep. 2019;9(1):10444.","journal-title":"Sci Rep"},{"issue":"18","key":"3845_CR24","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry M, Rose-Zerilli MJ, Ljungstrom V, Gibson J, Wang J, Walewska R, et al. Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing. Clin Cancer Res. 2015;21(18):4174\u201383.","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03845-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T14:05:19Z","timestamp":1732543519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03845-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03845-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}